REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-06-21

Reporting Person: YANCOPOULOS GEORGE (Director, President and Chief Scientific)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-12	Common Stock	G	82108	$0.0	Acquired	82108	Indirect
2021-06-21	Common Stock	S	738	$532.89	Disposed	81370	Indirect
2021-06-21	Common Stock	S	7494	$533.66	Disposed	73876	Indirect
2021-06-21	Common Stock	S	8236	$534.48	Disposed	65640	Indirect
2021-06-21	Common Stock	S	4154	$535.63	Disposed	61486	Indirect
2021-06-21	Common Stock	S	3768	$536.37	Disposed	57718	Indirect
2021-06-21	Common Stock	S	6636	$537.61	Disposed	51082	Indirect
2021-06-21	Common Stock	S	4868	$538.54	Disposed	46214	Indirect
2021-06-21	Common Stock	S	3306	$539.66	Disposed	42908	Indirect
2021-06-21	Common Stock	S	8099	$540.61	Disposed	34809	Indirect
2021-06-21	Common Stock	S	19911	$541.44	Disposed	14898	Indirect
2021-06-21	Common Stock	S	10514	$542.43	Disposed	4384	Indirect
2021-06-21	Common Stock	S	2276	$543.13	Disposed	2108	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Class A Stock	$	G	14000	Acquired		Common Stock (14000)	Indirect
2021-04-15	Class A Stock	$	G	14000	Disposed		Common Stock (14000)	Indirect
2021-04-15	Class A Stock	$	G	5383	Disposed		Common Stock (5383)	Indirect
2021-04-15	Class A Stock	$	G	5383	Acquired		Common Stock (5383)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	987483	Direct
Common Stock	5845	Indirect
Common Stock	211585	Indirect

Footnotes

F1: As investment trustee of trusts for the benefit of the reporting person's children.

F2: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3: Represents volume-weighted average price of sales of 738 shares of Company stock on June 21, 2021 at prices ranging from $532.56 to $532.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 7,494 shares of Company stock on June 21, 2021 at prices ranging from $533.14 to $533.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 8,236 shares of Company stock on June 21, 2021 at prices ranging from $534.01 to $534.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 4,154 shares of Company stock on June 21, 2021 at prices ranging from $535.05 to $535.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 3,768 shares of Company stock on June 21, 2021 at prices ranging from $536.02 to $536.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 6,636 shares of Company stock on June 21, 2021 at prices ranging from $537.05 to $537.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 4,868 shares of Company stock on June 21, 2021 at prices ranging from $538.01 to $538.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 3,306 shares of Company stock on June 21, 2021 at prices ranging from $539.14 to $539.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 8,099 shares of Company stock on June 21, 2021 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F12: Represents volume-weighted average price of sales of 19,911 shares of Company stock on June 21, 2021 at prices ranging from $541.00 to $541.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F13: Represents volume-weighted average price of sales of 10,514 shares of Company stock on June 21, 2021 at prices ranging from $542.00 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F14: Represents volume-weighted average price of sales of 2,276 shares of Company stock on June 21, 2021 at prices ranging from $543.01 to $543.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.

F15: Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.

F16: These shares of Class A Stock are presently convertible and such conversion feature does not expire.

F17: These shares of Class A Stock are held in a trust for the benefit of the reporting person's child, of which the reporting person is trustee.

F18: These shares of Class A Stock were held in custody for the benefit of the reporting person's child.